Mobile

A PHASE 2 MULTICENTER, DOUBLE BLIND, PLACEBO CONTROLLED, PARALLEL GROUP STUDY OF PF 04447943 IN SUBJECTS WITH MILD TO MODERATE ALZHEIMER’S DISEASE ON STABLE DONEPEZIL THERAPY

Mise à jour : Il y a 4 ans
Référence : EUCTR2010-020427-43

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

The primary objective of this Protocol is to assess the efficacy of PF 04447943, relative to placebo, on a performance based measure of cognition in subjects with mild to moderate AD who are on stable donepezil therapy.

Critère d'inclusion

  • Alzheimer's disease

Liens